Cutler Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Cutler Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,500	Closed	-$59K	–	5809
2020 Q3	$59K	Sell	1,500 -2,400	-62%	-$255K	﹤0.01%	1696
2020 Q2	$38K	Sell	3,900 -700	-15%	-$58.4K	﹤0.01%	1941
2020 Q1	$11K	Buy	4,600 +4,300	+1,433%	+$276K	﹤0.01%	2694
2019 Q4	$5K	Buy	+300	New	+$18.2K	﹤0.01%	3106
2019 Q3	–	Sell	-3,000	Closed	-$25K	–	4973
2019 Q2	$25K	Buy	3,000 +500	+20%	+$24.3K	﹤0.01%	2047
2019 Q1	$9K	Buy	+2,500	New	+$115K	﹤0.01%	2604
2018 Q3	–	Sell	-3,000	Closed	-$14K	–	4978
2018 Q2	$14K	Hold	3,000	–	–	﹤0.01%	2459
2018 Q1	$6K	Buy	+3,000	New	+$156K	﹤0.01%	3217

Cutler Group's MYOK Position: Q3 2019 in Review

Cutler Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2019, closing a stake of 97 shares — an estimated $4K sold.

Cutler Group first reported a position in MYOK in Q4 2017 and held it in 5 quarters. The position peaked at $492K in Q1 2018. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

Cutler Group reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Cutler Group sold 97 MyoKardia, Inc. Common Stock shares in Q3 2019, an estimated $4K.
Cutler Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
Cutler Group's MyoKardia, Inc. Common Stock position peaked at $492K in Q1 2018.
157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Cutler Group's 13F filing for Q3 2019, filed 28 Oct 2019.